Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Quarterly figures for Aptevo Therapeutics Inc., with source filings when available.
46 quarters. Mar 31, 2015 to Jun 30, 2026. USD.
Aptevo Therapeutics Inc. has filed its 10-Q within 37 to 45 days of period end across its last 8 quarters. The 10-K runs 45 to 90 days.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 14, 2026 · pre-market | Aug 14, 2026 | 45 d | 10-Q | — | — | -$5.31 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 13, 2026 · after-hours |
| May 13, 2026 |
| 43 d |
| 10-Q |
| — |
| — |
| -$6.41 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 26, 2026 · after-hours | Mar 26, 2026 | 85 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · after-hours | Nov 6, 2025 | 37 d | 10-Q | — | — | -$2.23 | |
| Q2 2025 | Jun 30, 2025 | Aug 11, 2025 · pre-market | Aug 11, 2025 | 42 d | 10-Q | — | — | -$151.29 | |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 · after-hours | May 15, 2025 | 45 d | 10-Q | — | — | -$1,581.81 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 14, 2025 · pre-market | Feb 14, 2025 | 45 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 7, 2024 · pre-market | Nov 7, 2024 | 38 d | 10-Q | — | — | -$357.86 | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · pre-market | Aug 8, 2024 | 39 d | 10-Q | — | — | -$1,236.96 | |
| Q1 2024 | Mar 31, 2024 | May 8, 2024 · pre-market | May 8, 2024 | 38 d | 10-Q | — | — | -$368.21 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 5, 2024 · pre-market | Mar 5, 2024 | 65 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 · pre-market | Nov 14, 2023 | 45 d | 10-Q | — | — | -$22.16 | |
| Q2 2023 | Jun 30, 2023 | Aug 10, 2023 · pre-market | Aug 10, 2023 | 41 d | 10-Q | — | — | -$53.95 | |
| Q1 2023 | Mar 31, 2023 | May 11, 2023 · pre-market | May 11, 2023 | 41 d | 10-Q | — | — | $17.38 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 30, 2023 · pre-market | Mar 30, 2023 | 89 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 10, 2022 · pre-market | Nov 10, 2022 | 41 d | 10-Q | $0.00 | −100.0% | -$1.50 | |
| Q2 2022 | Jun 30, 2022 | Aug 11, 2022 · pre-market | Aug 11, 2022 | 42 d | 10-Q | $0.00 | −100.0% | $5.58 | |
| Q1 2022 | Mar 31, 2022 | May 12, 2022 · pre-market | May 12, 2022 | 42 d | 10-Q | $3.11M | +28.6% | -$1.55 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 24, 2022 · pre-market | Mar 24, 2022 | 83 d | 10-K | $3.67M | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 12, 2021 · pre-market | Nov 12, 2021 | 43 d | 10-Q | $3.10M | +111.6% | -$1.43 | |
| Q2 2021 | Jun 30, 2021 | Aug 12, 2021 · after-hours | Aug 12, 2021 | 43 d | 10-Q | $3.11M | +557.5% | -$1.75 | |
| Q1 2021 | Mar 31, 2021 | May 11, 2021 · pre-market | May 11, 2021 | 41 d | 10-Q | $2.42M | — | -$1.64 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Mar 31, 2021 · pre-market | Mar 31, 2021 | 90 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | Nov 10, 2020 · after-hours | Nov 10, 2020 | 41 d | 10-Q | $1.46M | −83.8% | -$2.10 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 14, 2020 | 45 d | 10-Q | $473.00K | −93.6% | -$2.10 | |
| Q1 2020 | Mar 31, 2020 | — | May 13, 2020 | 43 d | 10-Q | — | — | $0.89 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | Mar 25, 2020 | 85 d | 10-K | $9.03M | +42.3% | — | |
| Q3 2019 | Sep 30, 2019 | Nov 7, 2019 · market hours | Nov 7, 2019 | 38 d | 10-Q | $9.01M | +54.7% | -$2.15 | |
| Q2 2019 | Jun 30, 2019 | Aug 9, 2019 · market hours | Aug 9, 2019 | 40 d | 10-Q | $7.36M | +7.8% | -$4.14 | |
| Q1 2019 | Mar 31, 2019 | May 9, 2019 · market hours | May 9, 2019 | 39 d | 10-Q | $7.02M | +72.5% | -$7.64 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | Mar 18, 2019 · market hours | Mar 18, 2019 | 77 d | 10-K | $6.35M | +125.2% | — | |
| Q3 2018 | Sep 30, 2018 | Nov 14, 2018 · after-hours | Nov 14, 2018 | 45 d | 10-Q | $5.82M | −5.6% | -$0.56 | |
| Q2 2018 | Jun 30, 2018 | Aug 9, 2018 · market hours | Aug 9, 2018 | 40 d | 10-Q | $6.83M | +93.6% | -$0.58 | |
| Q1 2018 | Mar 31, 2018 | May 10, 2018 · market hours | May 10, 2018 | 40 d | 10-Q | $4.07M | +90.1% | -$0.63 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | Mar 13, 2018 · market hours | Mar 13, 2018 | 72 d | 10-K | $2.82M | −67.9% | — | |
| Q3 2017 | Sep 30, 2017 | Nov 9, 2017 · after-hours | Nov 13, 2017 | 44 d | 10-Q | $6.17M | +119.2% | $1.75 | |
| Q2 2017 | Jun 30, 2017 | Aug 10, 2017 · market hours | Aug 10, 2017 | 41 d | 10-Q | $3.53M | −65.4% | -$0.53 | |
| Q1 2017 | Mar 31, 2017 | May 12, 2017 · market hours | May 12, 2017 | 42 d | 10-Q | $2.14M | −73.4% | -$0.48 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | Mar 31, 2017 · market hours | Mar 31, 2017 | 90 d | 10-K | $8.77M | +5.8% | -$0.74 | |
| Q3 2016 | Sep 30, 2016 | — | Nov 14, 2016 | 45 d | 10-Q | $2.82M | −57.1% | -$3.55 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 25, 2016 | 56 d | 10-Q | $10.19M | +43.8% | -$0.63 | |
| Q1 2016 | Mar 31, 2016 | — | — | — | — | $8.07M | −30.8% | -$0.64 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | — | — | — | $8.29M | — | -$0.88 | |
| Q3 2015 | Sep 30, 2015 | — | — | — | — | $6.56M | — | -$0.63 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $7.09M | — | -$0.88 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $11.66M | — | -$0.54 | |
